Protective effect of maternal immunization on birth outcomes: A data linkage study
Ahinsa Gunatilaka1, Daniel L Rolnik1, Michelle L Giles1,2
1Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
Summary
Maternal immunization with influenza and pertussis vaccines significantly reduced stillbirth and preterm birth (PTB) respectively. These findings support broader maternal vaccination programs, especially in low-income settings with high adverse pregnancy outcomes.
Area of Science:
- Obstetrics and Gynecology
- Immunology
- Public Health
Background:
- Adverse pregnancy outcomes like preterm birth (PTB) and stillbirth pose significant global health challenges.
- Maternal immunization is a strategy to protect both mother and fetus from infectious diseases.
Purpose of the Study:
- To investigate the impact of maternal immunization on the incidence of preterm birth and stillbirth.
- To assess the protective effects of influenza and pertussis vaccines during pregnancy.
Main Methods:
- A data linkage study involving 10,938 vaccinated and 4,029 unvaccinated women delivering singleton babies between January 2017 and May 2021.
- Poisson and Cox proportional hazards models were used to estimate incidence rates and hazard ratios, adjusting for confounders.
Main Results:
- Influenza vaccination was linked to a significant reduction in stillbirth (aHR, 0.55).
- Pertussis vaccination was associated with a significant reduction in preterm birth (aHR, 0.78) and a non-significant reduction in stillbirth (aHR, 0.59).
- Neither vaccine showed a significant impact on the other primary outcome.
Conclusions:
- Maternal immunization demonstrates potential protective effects against adverse pregnancy outcomes beyond direct pathogen prevention.
- Findings support the expansion of maternal immunization programs, particularly in low-income regions facing high rates of PTB and stillbirth.
Related Concept Videos
Development of Immunocompetence
386
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
386
Vaccinations
44.9K
Overview
44.9K
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K


